Why CBD products can’t make medical claims: rules explained

Written & posted by Ingrid Ferris

You’ve probably noticed that CBD brands talk about “wellness support” and “balance” rather than promising to treat specific conditions. That’s not marketing speak—it’s the law. The CBD industry operates under strict federal oversight, and companies face serious consequences for making unauthorized statements relating to health. Understanding why CBD products can’t make health-related claims helps you become a smarter consumer and sets realistic expectations about what these products can and cannot do.

The short answer: CBD is sold as a supplement, not a medicine. The longer answer involves regulatory frameworks, legal classifications, and consumer protection measures that shape every word on a CBD label.

Why CBD Products Can’t Make Medical Claims: The Regulatory Landscape

The federal government draws a clear line between approved drugs and supplements. Drugs undergo years of clinical trials to prove they safely and effectively address specific health issues. Supplements, on the other hand, support general wellness without targeting health problems.

CBD falls into the supplement category for most products on the market. Many legally available CBD products are classed as supplements and not medical products, which means they can’t claim to diagnose, remediate, or prevent any disease. This distinction isn’t arbitrary—it protects consumers from false promises and ensures that only rigorously tested products make specific health claims.

The regulatory picture continues to develop. Professional organizations state that further research is still needed, and the FDA is currently deciding how to regulate CBD. Until those decisions finalize, there’s no official guarantee on what CBD can do for you in terms of wellness support.

Why CBD Products Can’t Make Medical Claims: The Role of the FDA

The Food and Drug Administration oversees both drugs and dietary supplements, but with different levels of scrutiny. Before a drug reaches pharmacy shelves, manufacturers must prove it works for specific conditions through controlled studies. Dietary supplements don’t require pre-market approval, but they also can’t make claims about addressing or managing health problems.

CBD occupies unusual regulatory territory. The FDA has determined that CBD cannot be sold as a dietary supplement because it’s an active ingredient in Epidiolex, an FDA-approved prescription drug for certain rare conditions. This creates a regulatory gap: CBD isn’t approved as a supplement, yet most CBD products aren’t prescription drugs either.

Companies navigate this gap by marketing CBD for general wellness rather than health conditions. You’ll see phrases like “promotes calmness” or “supports balance” instead of “addresses stress” or “supports relaxation” rather than specific health claims. This careful language keeps brands compliant while still communicating potential uses.

How the Classification of CBD Impacts Marketing

Hemp-derived CBD products containing less than 0.3% THC are federally legal under the 2018 Farm Bill, which drew a clear line between hemp and marijuana. But legal doesn’t mean unregulated. The FDA actively monitors CBD marketing and issues warning letters to companies making unapproved health-related claims.

Between 2015 and 2019, 97.4% of companies receiving FDA warning letters had illicitly promoted CBD as an unapproved new drug. These violations covered claims about over 125 wellness-related issues. Even seemingly harmless statements like “relieves soreness” or “reduces discomfort” can cross the line into restricted territory if they suggest addressing a health condition.

This is why reputable brands frame their content as educational rather than prescriptive. Information provided is intended for general informational purposes only, not as professional health advice. Any statements about potential benefits are based on anecdotal evidence or limited studies, with no guarantee of specific results.

Implications for Brands and Consumers

Responsible CBD companies invest heavily in compliance. They craft product descriptions that highlight quality and transparency rather than making direct health promises. They provide detailed information about cannabinoid profiles, extraction methods, and ingredient sourcing—but stop short of suggesting their products address health concerns.

For consumers, this means doing your homework. Look for brands that provide Certificates of Analysis from third-party labs, which verify potency and purity. A 2018 study found that many CBD products sold online are inaccurately labeled, with 26% containing less CBD than stated and 43% containing more. Third-party testing catches these discrepancies before products reach your hands.

You should also consult healthcare professionals before adding CBD to your routine. The regulatory restrictions exist partly because CBD can interact with certain supplements or medications and may not be appropriate for everyone.

Guarding Consumer Trust

The best CBD brands build trust through honesty, not hype. They acknowledge the limits of current research while providing high-quality products for those who choose to try CBD.

At Myriam’s Hope Hemp, we focus on quality, clarity, and compassion rather than making specific health promises. We produce our hemp products in the United States using American suppliers, so we know exactly what goes into every bottle. Our products are free from chemicals and fillers, and we make detailed lab results available for every batch.

We also partner with Leaf411, a free cannabis-trained nurse hotline available at 844-LEAF411 (844-532-3411). Use code MHCBD to waive their consultation fee. This service provides expert guidance about the safe use of legal cannabis and hemp products. Professional support helps you make informed decisions without relying on marketing claims that shouldn’t be made in the first place.

Transparency extends to our disclaimers. Our products are not intended to diagnose, treat, cure, or prevent any disease, and these statements have not been evaluated by the Food and Drug Administration. We include this language not as fine print, but as a core principle that guides how we communicate about CBD.

Staying Informed and Exploring Quality CBD Options

The regulatory framework will continue evolving. New hemp regulations take effect in November 2026, with stricter THC limits and clearer definitions of legal cannabinoids. The FDA faces guidance deadlines in early 2026 to publish definitive lists of permitted naturally occurring cannabinoids.

While these changes unfold, your best strategy is staying informed. Visit educational resources that explain different cannabinoids like CBD, CBG, CBN, and CBDA. Learn how these compounds differ and what the current research suggests about their properties.

Choose brands that prioritize education over exaggeration. Look for companies that provide access to lab results, offer customer support, and connect you with professional guidance when needed. The absence of health-related claims doesn’t mean CBD products lack value—it means the industry is still building the evidence base that would support such claims.

Moving Forward With CBD Knowledge

Understanding why CBD products can’t make medical claims empowers you to evaluate products critically. The restrictions aren’t obstacles—they’re safeguards that protect consumers from false promises while the science catches up to the interest.

Reputable brands work within these guidelines by emphasizing quality, transparency, and education. They provide third-party lab results, offer access to professional guidance, and frame their content as informational rather than prescriptive. They acknowledge that effects vary from person to person and that there’s no guarantee of specific results.

If you’re ready to explore hemp-derived CBD from a brand that puts honesty first, browse our selection of tinctures, topicals, and specialized formulations. Every product comes with detailed lab results and the backing of our commitment to quality and clarity. And remember: honest answers and advice are always just a call away, whether through our team or through the Leaf411 nurse hotline at 844-LEAF411 (844-532-3411)—use code MHCBD to waive the consultation fee.

The CBD industry’s future depends on building trust through compliance and transparency. By understanding the regulatory framework and choosing responsible brands, you contribute to a marketplace that values consumer protection as much as product innovation.

Ingrid Ferris

Ingrid is a wellness expert, researcher, and passionate advocate for CBD. With a background rooted in holistic health and evidence-based research, she’s dedicated to helping others discover safe, effective, and natural approaches to wellness. Ingrid’s work reflects a commitment to high-quality, organic, and medically focused solutions, empowering readers to make informed choices for better health.